Orphan designation: Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor (lisocabtagene maraleucel), Treatment of diffuse large B-cell lymphoma, 17/07/2017, Positive

SEMrush
Orphan designation: Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor (lisocabtagene maraleucel), Treatment of diffuse large B-cell lymphoma, 17/07/2017, Positive
[automaticbacklinks]